{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:27:05Z","timestamp":1768508825525,"version":"3.49.0"},"posted":{"date-parts":[[2024,2,16]]},"group-title":"Pathology","reference-count":57,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,2,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>This study identifies and quantifies diverse pathological tau isoforms in the retina of both early and advanced-stage Alzheimer\u2019s disease (AD) and determines their relationship with disease status.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>A case-control study was conducted to investigate the accumulation of retinal neurofibrillary tangles (NFTs), paired helical filament (PHF)-tau, oligomeric tau (oligo-tau), hyperphosphorylated tau (p-tau), and citrullinated tau (Cit-tau) in relation to the respective brain pathology and cognitive dysfunction in mild cognitively impaired (MCI) and AD dementia patients versus normal cognition (NC) controls.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Design, setting and participants<\/jats:title>\n                  <jats:p>Eyes and brains from donors diagnosed with AD, MCI (due to AD), and NC were collected (n=75 in total), along with clinical and neuropathological data. Brain and retinal cross-sections\u2013in predefined superior-temporal and inferior-temporal (ST\/IT) subregions\u2013were subjected to histopathology analysis or Nanostring GeoMx digital spatial profiling.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Main outcomes and measure<\/jats:title>\n                  <jats:p>Retinal burden of NFTs (pretangles and mature tangles), PHF-tau, p-tau, oligo-tau, and Cit-tau was assessed in MCI and AD versus NC retinas. Pairwise correlations revealed associations between retinal and brain parameters and cognitive status.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    Increased retinal NFTs (1.8-fold, p=0.0494), PHF-tau (2.3-fold, p&lt;0.0001), oligo-tau (9.1-fold, p&lt;0.0001), CitR\n                    <jats:sub>209<\/jats:sub>\n                    -tau (4.3-fold, p&lt;0.0001), pSer202\/Thr205-tau (AT8; 4.1-fold, p&lt;0.0001), and pSer396-tau (2.8-fold, p=0.0015) were detected in AD patients. Retinas from MCI patients showed significant increases in NFTs (2.0-fold, p=0.0444), CitR\n                    <jats:sub>209<\/jats:sub>\n                    -tau (3.5-fold, p=0.0201), pSer396-tau (2.6-fold, p=0.0409), and, moreover, oligo-tau (5.8-fold, p=0.0045). Nanostring GeoMx quantification demonstrated upregulated retinal p-tau levels in MCI patients at phosphorylation sites of Ser214 (2.3-fold, p=0.0060), Ser396 (1.8-fold, p=0.0052), Ser404 (2.4-fold, p=0.0018), and Thr231 (3.3-fold, p=0.0028). Strong correlations were found between retinal tau forms to paired-brain pathology and cognitive status: a) retinal oligo-tau vs. Braak stage (r=0.60, P=0.0002), b) retinal PHF-tau vs. ABC average score (r=0.64, P=0.0043), c) retinal pSer396-tau vs. brain NFTs (r=0.68, P&lt;0.0001), and d) retinal pSer202\/Thr205-tau vs. MMSE scores (r= \u20130.77, P=0.0089).\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions and Relevance<\/jats:title>\n                  <jats:p>This study reveals increases in immature and mature retinal tau isoforms in MCI and AD patients, highlighting their relationship with brain pathology and cognition. The data provide strong incentive to further explore retinal tauopathy markers that may be useful for early detection and monitoring of AD staging through noninvasive retinal imaging.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.02.13.579999","type":"posted-content","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T12:30:11Z","timestamp":1708086611000},"source":"Crossref","is-referenced-by-count":0,"title":["Identification of retinal tau oligomers, citrullinated tau, and other tau isoforms in early and advanced AD and relations to disease status"],"prefix":"10.64898","author":[{"given":"Haoshen","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazanin","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosef","family":"Koronyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyah R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gila M.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousman","family":"Jallow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altan","family":"Rentsendorj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V Krishnan","family":"Ramanujan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Fert-Bober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei A.","family":"Kramerov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Ljubimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren G.","family":"Tourtellotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Hawes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith L.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakez","family":"Kayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maj-Linda B.","family":"Selenica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9718-5579","authenticated-orcid":false,"given":"Daniel C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieu-Trang","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-8442","authenticated-orcid":false,"given":"Maya","family":"Koronyo-Hamaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"4","key":"2024021908300580000_2024.02.13.579999v1.1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","year":"2014","journal-title":"JAMA Neurol"},{"key":"2024021908300580000_2024.02.13.579999v1.2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00083"},{"key":"2024021908300580000_2024.02.13.579999v1.3","doi-asserted-by":"publisher","DOI":"10.1042\/BST20120134"},{"issue":"30","key":"2024021908300580000_2024.02.13.579999v1.4","first-page":"9636897211033705","volume":"2021","year":"2021","journal-title":"Cell Transplant"},{"key":"2024021908300580000_2024.02.13.579999v1.5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.14.5646"},{"key":"2024021908300580000_2024.02.13.579999v1.6","doi-asserted-by":"publisher","DOI":"10.2478\/s13380-012-0032-y"},{"issue":"6","key":"2024021908300580000_2024.02.13.579999v1.7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals","volume":"77","year":"2020","journal-title":"JAMA Neurol"},{"key":"2024021908300580000_2024.02.13.579999v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"2024021908300580000_2024.02.13.579999v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"issue":"338","key":"2024021908300580000_2024.02.13.579999v1.10","first-page":"338r","article-title":"Tau and Abeta imaging, CSF measures, and cognition in Alzheimer\u2019s disease","volume":"8","year":"2016","journal-title":"Sci Transl Med"},{"issue":"4","key":"2024021908300580000_2024.02.13.579999v1.11","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/brain\/awac329","article-title":"Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals","volume":"146","year":"2023","journal-title":"Brain"},{"issue":"6","key":"2024021908300580000_2024.02.13.579999v1.12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial","volume":"330","year":"2023","journal-title":"JAMA"},{"key":"2024021908300580000_2024.02.13.579999v1.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJ-Moa2212948"},{"key":"2024021908300580000_2024.02.13.579999v1.14","doi-asserted-by":"crossref","unstructured":"Erskine L , Herrera E . Connecting the retina to the brain. ASN Neuro. 2014;6(6).","DOI":"10.1177\/1759091414562107"},{"key":"2024021908300580000_2024.02.13.579999v1.15","unstructured":"Purves D ea , eds. The Retina. Neuroscience 2nd ed. 2001:Chapters 11 and 12. Sunderland (MA): Sinauer Associates; 2001."},{"key":"2024021908300580000_2024.02.13.579999v1.16","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006213"},{"key":"2024021908300580000_2024.02.13.579999v1.17","doi-asserted-by":"crossref","unstructured":"Alber J , Bouwman F , den Haan J , et al. Retina pathology as a target for biomarkers for Alzheimer\u2019s disease: Current status, ophthalmopathological background, challenges, and future directions. Alzheimers Dement. 2023.","DOI":"10.1002\/alz.13529"},{"issue":"1","key":"2024021908300580000_2024.02.13.579999v1.18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","article-title":"Amyloid-beta and phosphorylated tau in post-mortem Alzheimer\u2019s disease retinas","volume":"6","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"2024021908300580000_2024.02.13.579999v1.19","doi-asserted-by":"crossref","first-page":"pgac164","DOI":"10.1093\/pnasnexus\/pgac164","article-title":"Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid beta-protein and phosphorylated tau","volume":"1","year":"2022","journal-title":"PNAS Nexus"},{"key":"2024021908300580000_2024.02.13.579999v1.20","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00925"},{"key":"2024021908300580000_2024.02.13.579999v1.21","doi-asserted-by":"crossref","unstructured":"Hart de Ruyter FJ , Morrema THJ , den Haan J , et al. Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer\u2019s disease and primary tauopathies. Acta Neuropathol. 2022.","DOI":"10.1007\/s00401-022-02525-1"},{"key":"2024021908300580000_2024.02.13.579999v1.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608213150804"},{"key":"2024021908300580000_2024.02.13.579999v1.23","doi-asserted-by":"crossref","unstructured":"Koronyo Y , Biggs D , Barron E , et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. 2017;2(16).","DOI":"10.1172\/jci.insight.93621"},{"issue":"4","key":"2024021908300580000_2024.02.13.579999v1.24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-023-02548-2","article-title":"Retinal pathological features and proteome signatures of Alzheimer\u2019s disease","volume":"145","year":"2023","journal-title":"Acta Neuropathol"},{"key":"2024021908300580000_2024.02.13.579999v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.06.020"},{"key":"2024021908300580000_2024.02.13.579999v1.26","doi-asserted-by":"crossref","unstructured":"Mirzaei N , Shi H , Oviatt M , et al. Alzheimer\u2019s Retinopathy: Seeing Disease in the Eyes. Frontiers in Neuroscience. 2020;14(921).","DOI":"10.3389\/fnins.2020.00921"},{"key":"2024021908300580000_2024.02.13.579999v1.27","doi-asserted-by":"crossref","unstructured":"Shi H , Koronyo Y , Fuchs DT , et al. Retinal arterial Abeta(40) deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients. Alzheimers Dement. 2023.","DOI":"10.1002\/alz.13086"},{"key":"2024021908300580000_2024.02.13.579999v1.28","doi-asserted-by":"crossref","unstructured":"Shi H , Koronyo Y , Rentsendorj A , et al. Retinal Vasculopathy in Alzheimer\u2019s Disease. Front Neurosci. 2021;15:731614.","DOI":"10.3389\/fnins.2021.731614"},{"key":"2024021908300580000_2024.02.13.579999v1.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02134-w"},{"issue":"1","key":"2024021908300580000_2024.02.13.579999v1.30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","article-title":"Muller cell degeneration and microglial dysfunction in the Alzheimer\u2019s retina","volume":"10","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"2024021908300580000_2024.02.13.579999v1.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053547"},{"key":"2024021908300580000_2024.02.13.579999v1.32","doi-asserted-by":"crossref","unstructured":"Walkiewicz G , Ronisz A , Van Ginderdeuren R , et al. Primary retinal tauopathy: A tauopathy with a distinct molecular pattern. Alzheimers Dement. 2023.","DOI":"10.1002\/alz.13424"},{"key":"2024021908300580000_2024.02.13.579999v1.33","doi-asserted-by":"publisher","DOI":"10.1007\/s004010100423"},{"key":"2024021908300580000_2024.02.13.579999v1.34","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E"},{"key":"2024021908300580000_2024.02.13.579999v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12321"},{"key":"2024021908300580000_2024.02.13.579999v1.36","doi-asserted-by":"crossref","unstructured":"Lasagna-Reeves CA , Castillo-Carranza DL , Sengupta U , et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci Rep. 2012;2:700.","DOI":"10.1038\/srep00700"},{"key":"2024021908300580000_2024.02.13.579999v1.37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv081"},{"issue":"1","key":"2024021908300580000_2024.02.13.579999v1.38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","article-title":"Intersection of pathological tau and microglia at the synapse","volume":"7","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"2024021908300580000_2024.02.13.579999v1.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04126-3"},{"key":"2024021908300580000_2024.02.13.579999v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.03.004"},{"key":"2024021908300580000_2024.02.13.579999v1.41","doi-asserted-by":"crossref","unstructured":"Zhang H , Cao Y , Ma L , Wei Y , Li H . Possible Mechanisms of Tau Spread and Toxicity in Alzheimer\u2019s Disease. Front Cell Dev Biol. 2021;9:707268.","DOI":"10.3389\/fcell.2021.707268"},{"key":"2024021908300580000_2024.02.13.579999v1.42","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3181919a48"},{"key":"2024021908300580000_2024.02.13.579999v1.43","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000129697.01779.0A"},{"key":"2024021908300580000_2024.02.13.579999v1.44","doi-asserted-by":"publisher","DOI":"10.1097\/nen.0b013e31815c5efb"},{"key":"2024021908300580000_2024.02.13.579999v1.45","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.1.105"},{"key":"2024021908300580000_2024.02.13.579999v1.46","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.1.38"},{"key":"2024021908300580000_2024.02.13.579999v1.47","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.3.326"},{"key":"2024021908300580000_2024.02.13.579999v1.48","doi-asserted-by":"publisher","DOI":"10.1159\/000335154"},{"key":"2024021908300580000_2024.02.13.579999v1.49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-199851"},{"key":"2024021908300580000_2024.02.13.579999v1.50","doi-asserted-by":"crossref","unstructured":"Niewiadomska G , Niewiadomski W , Steczkowska M , Gasiorowska A . Tau Oligomers Neurotoxicity. Life (Basel). 2021;11(1).","DOI":"10.3390\/life11010028"},{"issue":"1","key":"2024021908300580000_2024.02.13.579999v1.51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-022-01324-9","article-title":"Differential protein expression in the hippocampi of resilient individuals identified by digital spatial profiling","volume":"10","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"2024021908300580000_2024.02.13.579999v1.52","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012921"},{"issue":"1","key":"2024021908300580000_2024.02.13.579999v1.53","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0021-9258(18)48531-6","article-title":"Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau","volume":"267","year":"1992","journal-title":"J Biol Chem"},{"issue":"6","key":"2024021908300580000_2024.02.13.579999v1.54","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00702-004-0221-0","article-title":"Post-translational modifications of tau protein in Alzheimer\u2019s disease","volume":"112","year":"2005","journal-title":"J Neural Transm (Vienna)."},{"key":"2024021908300580000_2024.02.13.579999v1.55","first-page":"7592851","article-title":"An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders","volume":"2019","year":"2019","journal-title":"J Immunol Res"},{"issue":"5","key":"2024021908300580000_2024.02.13.579999v1.56","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jnen\/nlx020","article-title":"Absence of Alzheimer Disease Neuropathologic Changes in Eyes of Subjects With Alzheimer Disease","volume":"76","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024021908300580000_2024.02.13.579999v1.57","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12070"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.02.13.579999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:57:50Z","timestamp":1768456670000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.02.13.579999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":57,"URL":"https:\/\/doi.org\/10.1101\/2024.02.13.579999","relation":{},"subject":[],"published":{"date-parts":[[2024,2,16]]},"subtype":"preprint"}}